Article Information
History
- April 25, 2018.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Pierandrea Muglia1,*,
- Michele Filosi2,
- Lucio Da Ros3,
- Tony Kam-Thong4,
- Franco Nardocci5,
- Elisabetta Trabetti6,
- Emiliangelo Ratti7,
- Paolo Rizzini3,
- Alessandro Zuddas8,
- Bernardo Dalla Bernardina9,
- Enrico Domenici2,10,*,
- the Italian Autism Network
- 1UCB Pharma, Belgium
- 2Centre for Integrative Biology, University of Trento, Trento, Italy
- 3Fondazione Smith Kline, Verona, Italy
- 4Roche Pharmaceutical Research and Early Development (pRED), Roche Innovation Center, Basel, Grenzacherstrasse 124, Switzerland
- 5Neuropsichiatria infantile, Modena, Italy
- 6Department of Neurosciences, Biomedicine and Movement Sciences, Section of Biology and Genetics, University of Verona, Verona, Italy
- 7Central Nervous System (CNS) Therapeutic Area Unit, Takeda, Boston, USA
- 8Child and Adolescent Psychiatry Unit, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy
- 9Servizio di Neuropsichiatria Infantile Azienda Ospedaliera Istituti Ospitalieri di Verona Policlinico G.B. Rossi, Verona, Italy
- 10The Microsoft Research - University of Trento Centre for Computational and Systems Biology, Rovereto (TN), Italy
- ↵*Corresponding Authors Pierandrea Muglia, M.D., UCB Pharma Belgium